mutations and complicated kar yotype. It follows a linear evolution within the CLL clone in the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding locations from the genome, are generally situated in Lively promoters or enhancers, and modify the binding web sites of a variety of transcriptio